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Abstract
Background:  Normal tension glaucoma is a major subtype of glaucoma, associated with
intraocular pressures that are within the statistically normal range of the population. Monogenic
forms following classical inheritance patterns are rare in this glaucoma subtype. Instead, multigenic
inheritance is proposed for the majority of cases. The present study tested common sequence
variants in candidate genes for association with normal tension glaucoma in the German population.
Methods: Ninety-eight SNPs were selected to tag the common genetic variation in nine genes,
namely OPTN (optineurin), RDX (radixin), SNX16 (sorting nexin 16), OPA1 (optic atrophy 1),
MFN1 (mitofusin 1), MFN2 (mitofusin 2), PARL (presenilin associated, rhomboid-like), SOD2
(superoxide dismutase 2, mitochondrial) and CYP1B1 (cytochrome P450, family 1, subfamily B,
polypeptide 1). These SNPs were genotyped in 285 cases and 282 fully evaluated matched controls.
Statistical analyses comprised single polymorphism association as well as haplogroup based
association testing.
Results: Results suggested that genetic variation in five of the candidate genes (RDX, SNX16,
OPA1, SOD2 and CYP1B1) is unlikely to confer major risk to develop normal tension glaucoma in
the German population. In contrast, we observed a trend towards association of single SNPs in
OPTN, MFN1, MFN2 and PARL. The SNPs of OPTN, MFN2 and PARL were further analysed by
multimarker haplotype-based association testing. We identified a risk haplotype being more
frequent in patients and a vice versa situation for the complementary protective haplotype in each
of the three genes.
Conclusion: Common variants of OPTN, PARL, MFN1 and MFN2 should be analysed in other
cohorts to confirm their involvement in normal tension glaucoma.
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Background
The term glaucoma describes a heterogeneous group of
optic neuropathies. Yet progressive loss of retinal gan-
glion cells (RGCs) and optic nerve axons, corresponding
visual field loss and characteristic optic nerve head cup-
ping is common in all forms of glaucoma. The three major
risk factors for the development of glaucoma are elevated
intraocular pressure (IOP), advanced age and a positive
family history. It is estimated, that by 2010, 60 million
people will suffer from glaucoma and that the disease will
be the second leading cause of blindness worldwide [1].
Primary open angle glaucoma (POAG) is the most fre-
quent of all glaucoma types. In approximately one third of
all Caucasian POAG patients the IOP is within the average
range of 10-21 mmHg. Nonetheless such patients with
normal tension glaucoma (NTG) show typical pathologi-
cal cupping of the optic nerve as well as characteristic vis-
ual field defects [2,3].
First degree relatives of glaucoma patients have an ele-
vated risk to develop glaucoma themselves, indicating
that genetic risk factors are involved in the etiology of
POAG.
Though at least 14 loci have been linked to POAG
(GLC1A-GLC1N), only three causative genes have been
identified to date: myocilin (MYOC/GLC1A), optineurin
(OPTN/GLC1E), and WD repeat domain 36 (WDR36/
GLC1G). Altogether, mutations in these three genes
account for less than 10% of POAG cases [4]. In addition,
association studies have implicated more than 20 other
genes in POAG [5]. Most of these genes were investigated
only in single studies whereas the OPA1 gene, which is
linked to autosomal dominant optic atrophy, has been
subject of multiple studies. However, results were contra-
dictory [6-11].
Taken together, true monogenic forms following classical
inheritance patterns are rare in POAG. It is therefore gen-
erally accepted that the majority of cases are most likely to
evolve from multigenic inheritance, i.e. genes interacting
synergistically to cause the condition [12].
Therefore, association studies may be suitable to unravel
the genetic etiology of multigenic human diseases like
glaucoma. The recent identification and replication of the
LOXL1 gene as a risk factor for pseudoexfoliation glau-
coma [13] clearly demonstrates the power of association
studies in glaucoma research.
In the present study, we performed a case-control study to
identify genetic risk factors for the development of NTG.
A tagging single nucleotide polymorphism (tagSNP)
approach based on linkage disequilibrium (LD) blocks
was used to determine the frequency of common
sequence variants in nine candidate genes. The genes we
analysed were OPTN (optineurin), RDX (radixin), SNX16
(sorting nexin 16), OPA1 (optic atrophy 1), MFN1 (mito-
fusin 1), MFN2 (mitofusin 2), PARL (presenilin associ-
ated, rhomboid-like), SOD2 (superoxide dismutase 2,
mitochondrial) and CYP1B1 (cytochrome P450, family 1,
subfamily B, polypeptide 1).
Mutations in the OPTN gene were initially reported in
16.7% of families with hereditary POAG and NTG [14].
Follow-up studies in unselected cohorts however indi-
cated that coding OPTN sequence variants are only a rare
cause of POAG or NTG in different populations including
our own German NTG cohort [15-18]. This however does
not rule out that other common gene variations in OPTN
not yet investigated (e. g. in introns or noncoding flanking
regions) may show up as risk associated variants in a case
control study. In addition to OPTN we also considered
RDX and SNX16, since both genes are linked with OPTN
expression [19].
Mutations in the OPA1 gene are a frequent cause of auto-
somal dominant optic atrophy [20]. In addition, com-
mon sequence variants in the OPA1 gene have been
associated with POAG or specifically NTG, though the
findings could not be replicated in all populations [6-11].
In the present study, we extended the analysis by genotyp-
ing 16 common variants in the genomic region of the
OPA1 gene.
Two genes that encode functional interaction partners of
the OPA1 protein were also included in our study: MFN1,
which acts in concert with OPA1 in the mitochondrial fis-
sion and fusion process [21], and PARL, which encodes a
processing protease for OPA1 [22-24]. We also analysed
the MFN2 gene, as the MFN2 protein shows functional
overlap with OPA1 [25].
The SOD2 gene encodes the Mn2 dependent superoxide
dismutase that acts as a primary scavenger of reactive oxy-
gen species in mitochondria. Oxidative stress is proposed
to be involved in the etiology of glaucoma [26] and
increased expression of the SOD2 gene was observed in
the aqueous humor of glaucoma patients [27].
Mutations in the CYP1B1 gene cause an autosomal reces-
sive form of primary congenital glaucoma [28] and two
common sequence variants (Val432Leu and Asn453Ser)
in the CYP1B1 gene are proposed to act as a risk factor for
the development of POAG [29] and to influence clinical
features like optic disk cupping and visual field deteriora-
tion in POAG patients [30]. Moreover, a very recent study
showed that heterozygous CYP1B1 mutations with absent
or reduced relative enzymatic activity are associated with
POAG [31].BMC Medical Genetics 2009, 10:91 http://www.biomedcentral.com/1471-2350/10/91
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The goal of the present study was to determine whether
common sequence variants in nine functionally defined
candidate genes influence the risk to develop NTG in a
large homogeneous patient cohort and would thus be
worthy of more detailed examination.
Methods
Study samples
285 unrelated German patients with a diagnosis of NTG
were recruited at the University Eye Hospital Wuerzburg,
Germany. All patients were traced back to the third gener-
ation to reconfirm ethnicity. NTG was defined by (1) the
presence of typical glaucomatous optic neuropathy with
corresponding visual field loss, (2) open drainage angles
on gonioscopy, (3) absence of a secondary cause for glau-
comatous optic neuropathy, such as previously elevated
IOP after trauma, a period of steroid administration or
uveitis, and (4) IOP measures of untreated NTG continu-
ously 21 mmHg or lower on repeated diurnal testing (five
readings between 8:00 AM and 6:00 PM). The median of
readings was required to be 21 mm Hg or less, with no
reading above 24 mm Hg and no more than one reading
of 23 or 24 mm Hg. IOP readings were correlated with
corneal thickness. Patients did not have evidence of high
myopia or congenital ocular abnormality and had no
other cause than glaucoma for disc changes and visual
field loss. Disc size and parameters were evaluated by con-
focal examination (Heidelberg Retina Tomograph). To
minimize interobserver variability, more than 95% of
patients were examined by the same ophthalmologist. All
patients had a long term follow-up to ensure diagnosis of
NTG with a maximum of certainty. In large part, NTG
patients underwent a neurological examination to exclude
an intracerebral expansion. Sonography was used to rule
out aortic stenosis.
The control cohort comprised 282 unrelated German
individuals, matched with the patient cohort for age, gen-
der distribution and geographical origin. Ophthalmic
examination was performed in all control subjects,
including IOP measurement and ophthalmoscopy of the
optic disc, to ascertain an IOP in the normal range (<21
mmHG) and the absence of glaucomatous disc change.
Controls had no family history of glaucoma.
This study adhered to the tenets of the Declaration of Hel-
sinki. Written informed consent was obtained from all
subjects and the study was approved by the ethics com-
mittees of the University of Tuebingen, the University of
Wuerzburg and the University of Erlangen-Nuremberg.
The average age of the patient group was 64.7 ± 13.9 years
(controls: 66.9 ± 13.1 years) with a median of 67 years
(controls: 68 years). Thirty-four percent of the NTG
patients were male and 66% were female, while 41% of
the controls were male and 59% were female.
Isolation of DNA, SNP selection and genotyping
DNA was extracted from peripheral blood lymphocytes
using the Magnetic Separation Module I from Chemagen
using DNA chemistry (Chemagic DNA Blood Kit Special;
Chemagen AG, Baesweiler, Germany).
Nine genes were investigated in this study, namely OPTN,
RDX, SNX16, OPA1, MFN1, MFN2, PARL, SOD2 and
CYP1B1.
Linkage disequilibrium (LD) blocks were defined using
the algorithm by Gabriel and coworkers [32] imple-
mented in Haploview [33] (version 4.1) on the
HapMap31 CEPH (Utah residents with ancestry from
northern and western Europe) data. LD blocks covered the
chromosomal regions of these genes extending to the
neighbouring genes. TagSNPs capturing LD blocks were
selected to define haplotypes having a frequency of at least
0.1 and a minor allele frequency (MAF) of 0.1 or higher.
Additional non-tagging SNPs were genotyped in the
OPA1 gene (rs166850 and rs10451941) and in the SOD2
gene (rs4880), respectively. For the CYP1B1 gene, only
two coding SNPs were selected for genotyping (rs1056836
and rs1800440).
The number of SNPs genotyped in each gene is shown in
Table 1. All SNPs were genotyped with TaqMan assays
(Applied Biosystems, Foster City, USA). Assay IDs and ori-
entation of design strands are given in Additional file 1.
Reactions were prepared according to the manufacturer's
instructions and run on a sequence detection system (ABI
7500) using standard protocols. Sequence data was ana-
lysed using Sequence Detection Software version 1.2.3.
For quality-control reasons, 28 of the 98 TaqMan assays
used in this study were selected randomly to confirm
standard individual genotypes. Altogether, 1294 genotyp-
ing reactions were performed on 58 CEPH individuals.
These CEPH individuals comprised 48 individuals that
are identical with the triplets used in the HapMap [34]
project and 10 additional members of one of the families.
Genotyping results were checked for pedigree consistency
and a cross comparison with HapMap data revealed a
100% concordance.
Statistical analysis
All statistical analyses were performed using PLINK [35]
(version 1.05). The minimum genotyping rate for SNPs
and individuals to be included in the statistical analyses
was set to 90%.
Hardy-Weinberg equilibrium was assessed by using an
exact test. Case-control association testing of single SNPs
was performed by logistic regression. Multiple compari-
sons of SNPs covering all investigated genes were cor-
rected using the Bonferroni method.BMC Medical Genetics 2009, 10:91 http://www.biomedcentral.com/1471-2350/10/91
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Interaction of SNPs was analysed by an SNP × SNP epista-
sis test with subsequent correction for multiple compari-
sons by the Bonferroni method. Haplotype-based case
control association testing was assessed as implemented
in PLINK.
Results
Ninety-eight SNPs were selected to tag the common
genetic variation in OPTN, RDX, SNX16, OPA1, MFN1,
MFN2, PARL, SOD2 and CYP1B1.
One of these (RDX: rs1676536) was excluded from fur-
ther analysis due to a low genotyping rate. The remaining
panel of SNPs was genotyped in a case-control study in
285 patients with NTG and 282 healthy controls of Ger-
man origin. The average number of individuals remaining
for analysis was 554.31 ± 2.5 (median 555) per SNP and
the average genotyping rate in these individuals was 0.995
± 0.007 (median 0.997). The size of the chromosomal
regions and the number of SNPs genotyped in each gene
are shown in Table 1. For all SNPs, genotype distributions
in patients and controls were consistent with Hardy-
Weinberg equilibrium.
We found no evidence of association between NTG and
RDX, SNX16, OPA1, SOD2 and CYP1B1. Entire allele fre-
quencies and detailed results of the logistic regression of
single SNP association testing are provided in Additional
file 1.
We identified a nominally significant association of NTG
with four SNPs in OPTN (rs10796021, rs3829923,
rs7921853 and rs765884), three almost consecutive SNPs
in the MFN2 gene (rs873458, rs2295281 and
rs11588779), two close neighboring SNPs in PARL
(rs1000002 and rs1402003) and one SNP in the MFN1
gene (rs2111534) (Table 2). Genewise case-control com-
parison of multimarker haplotypes derived from the SNPs
in OPTN, MFN2 and PARL revealed two complementary
common haplotypes for each gene. The differences of
these haplotype frequencies between cases and controls
were nominally significant (Table 3). In PARL, a very rare
haplotype showed a nominal association with NTG
(Table 3).
For correcting data for multiple comparisons we also con-
sidered our previously performed association study with
the same cohorts [36]. Since a p value of less than 4.808 ×
10-4 was considered to be significant applying Bonferroni
adjustment over the whole study, no significance of any
single SNP association in any gene was further observed
after correction for multiple comparisons. The epistasis
Table 1: Chromosomal regions of genotyped SNPs
Gene CHR included chromosomal region (bp) number of genotyped SNPs
CYP1B1 26 4 2
MFN1 3 60496 5
MFN2 1 55573 4
OPA1 3 208893 16
OPTN 10 106314 29
PARL 3 109822 7
RDX 11 151216 14
SNX16 8 204923 11
SOD2 6 123647 10
CHR, chromosome; bp, basepairs
Table 2: Allele frequencies and summary statistics for significant SNPs before adjustment for multiple testing
Gene1 SNP MA MAF patients MAF controls OR L95 U95 p
OPTN rs10796021 C 0.471 0.405 1.316 1.022 1.695 0.033
OPTN rs3829923 T 0.375 0.444 0.768 0.602 0.980 0.034
OPTN rs7921853 T 0.498 0.415 1.356 1.069 1.721 0.012
OPTN rs765884 C 0.315 0.224 1.558 1.179 2.059 1.838 × 10-3
MFN1 rs2111534 A 0.384 0.450 0,748 0.583 0.960 0.023
MFN2 rs873458 G 0.496 0.432 1.292 1.019 1.639 0.035
MFN2 rs2295281 C 0.493 0.423 1.327 1.044 1.687 0.021
MFN2 rs11588779 T 0.221 0.282 0.721 0.547 0.950 0.020
PARL rs1000002 C 0.539 0.437 1.478 1.091 2.002 0.012
PARL rs1402003 G 0.464 0.368 1.471 1.079 2.006 0.015
1Refers to the gene for which LD blocks were calculated. MA, minor allele; MAF, minor allele frequency; OR, odds ratio; L95, confidence interval 
95% lower bound; U95, confidence interval 95% upper boundBMC Medical Genetics 2009, 10:91 http://www.biomedcentral.com/1471-2350/10/91
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test for interaction of SNPs revealed no significant result
after correction for multiple testing (data not shown).
Discussion
There is a growing number of single gene or single variant
based association studies in glaucoma. Our study based
on the genotyping of tagSNPs to maximize genetic cover-
age of nine candidate genes (OPTN, RDX, SNX16, OPA1,
MFN1, MFN2, PARL, SOD2 and CYP1B1). In total, we
investigated 98 SNPs in 285 NTG patients and 282 con-
trols and identified a trend towards association of NTG
with common sequence variants of OPTN, MFN1, MFN2
and PARL.
No association study with RDX, SNX16 and SOD2 has
been performed in glaucoma patients before. We hypoth-
esized that genetic differences in these genes could confer
risk to NTG since data from our previous work as well as
from the literature point to a putative involvement of
these genes in glaucoma related pathogenesis. However,
our approach failed to find any association of NTG with
any of the 35 examined SNPs in these genes suggesting
that genetic variants at these loci are not of high relevance
in the development of NTG in German patients.
In patients with NTG, the appearance of the optic nerve
head is similar to that in autosomal dominant optic atro-
phy (ADOA) [37]. These similarities make OPA1, the
major gene involved in ADOA [20], an excellent candi-
date gene for glaucoma, particularly NTG. Several studies
showed an association of two intron 8 polymorphisms
(rs166850 and rs10451941) in the OPA1 gene with NTG
in Caucasians [6,7]. These studies were based on relatively
small sample sizes comprising 61 to 83 patients. A more
comprehensive study with 279 Caucasian POAG patients
reported a lack of association similar to our findings [11].
As we did not only genotype SNPs rs166850 and
rs10451941 but 14 additional SNPs within a 209 kb
region encompassing the OPA1 gene, our results are more
conclusive since we cover the genetic population variabil-
ity of the entire OPA1 gene. Considering patient number
and cohort homogeneity as well as the size of the analysed
OPA1 region, our study is the most comprehensive one
on this matter to date.
Mutations in the CYP1B1 gene are a frequent cause of pri-
mary congenital glaucoma. In addition, two common
coding polymorphisms in this gene might contribute to
the development of POAG. The Leu432Val variant
(rs1056836) is associated with POAG in Indian patients
[29] and the Asn453Ser (rs1800440) variant that is not
directly associated with disease but with clinical features
like optic disk cupping and visual field deterioration in
French POAG patients [30]. We were not able to indentify
an association of either of these two SNPs with NTG in
our cohort. These conflicting findings may result from
phenotypic differences (e.g. IOP level) between NTG and
POAG. Inconsistent results may also be due to the large
variability of CYP1B1 allele frequency distribution among
different populations or the modest proportion of con-
trols among the total number of samples in the previous
studies [29,30].
Table 3: Summary statistics on haplotype-based association
Gene SNP identifiers and omnibus association Haplotype F patients F controls χ2 p
OPTN rs10796021|rs3829923|rs7921853|rs765884 TTGT 0.257 0.327 5.905 0.015
pomnibus = 0.014 CCGT 0.125 0.142 0.590 0.443
χ2 
omnibus = 23.67 TCTT 0.129 0.119 0.243 0.622
CCTC 0.187 0.093 18.170 2.021 × 10-5
TCTC 0.062 0.073 0.484 0.487
CCTT 0.072 0.070 0.019 0.890
CTGT 0.048 0.056 0.293 0.588
TTTT 0.036 0.040 0.083 0.773
TCGT 0.023 0.031 0.728 0.394
CCGC 0.029 0.029 0.003 0.959
CTTC 0.014 0.013 0.023 0.880
TTGC 0.018 0.009 1.611 0.204
MFN2 rs873458|rs2295281|rs11588779 ATC 0.410 0.420 0.1083 0.742
pomnibus = 0.018 GCC 0.359 0.286 6.541 0.011
χ2 
omnibus = 11.97 ATT 0.091 0.147 8.334 3.891 × 10-3
GCT 0.131 0.135 0.039 0.843
GTC 0.009 0.011 0.099 0.753
PARL rs1000002|rs1402003 TA 0.461 0.540 4.049 0.044
pomnibus = 7.619 × 10-4 CG 0.464 0.344 9.758 1.786 × 10-3
χ2 
omnibus = 16.84 CA 0.075 0.093 0.7123 0.399
TG 0 0.023 8.480 3.590 × 10-3
F, frequencyBMC Medical Genetics 2009, 10:91 http://www.biomedcentral.com/1471-2350/10/91
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The association of OPTN, PARL, MFN1 and MFN2 com-
mon sequence variants we observed justifies a more exten-
sive analysis. The single SNP associations observed before
adjustment for multiple comparisons are supported by
multimarker haplotype-based associations that we found
for OPTN, MFN2 and PARL. In each of the three genes, we
identified a nominally significant risk haplotype being
more frequent in patients and a vice versa situation for the
complementary protective haplotype, both being present
at common frequencies in either cohort. The relative risk
for homozygous individuals of the OPTN risk haplotype
which showed the strongest of all associations is 8.905
(95% CI: 1.477-54.313).
OPTN is one of three causative genes that have been
linked to POAG [14]. Nonetheless, more than 25 studies
dealing with the impact of OPTN coding and flanking
intronic variants on glaucoma show that disease-causing
sequence alterations are rare in POAG/NTG patients and
families. However, the OPTN gene may be a risk factor in
multigenic inheritance as synergistic effects with the two
other POAG genes myocilin and WD repeat domain 36
have been suggested [38-40]. Yet, the mechanistic involve-
ment of OPTN in glaucoma pathogenesis remains elusive.
No case-control association study based on common gene
variants has been performed for the complete chromo-
somal region of OPTN to date. Our study implicates that
apart from OPTN mutations observed in monogenic
inheritance of glaucoma also OPTN common allelic vari-
ants may influence an individual's susceptibility for devel-
oping NTG in a multigenic inheritance pattern.
MFN1 and MFN2 are nuclear encoded mitochondrial
membrane proteins that interact with each other to facili-
tate mitochondrial targeting. MFN2 and OPA1 act in con-
cert and conduct complementary functions in
maintaining balance of mitochondrial fusion and fission
events in the highly dynamic mitochondrial network
architecture processes [25,41,42]. Likewise, PARL is a
nuclear encoded mitochondrial protein and has been sug-
gested to participate in OPA1 processing and apoptotic
processes by regulation of cytochrome c release via OPA1-
dependent cristae remodeling [22,43].
A possible involvement of mitochondrial function in
mechanisms of glaucoma development has been indi-
cated before [44-46]. According to the common disease-
common variant hypothesis, multiple variants may each
contribute a small additive or multiplicative effect to the
disease phenotype. As mentioned above, the nuclear
encoded mitochondrial genes OPA1, MFN1, MFN2 and
PARL share functional overlap and/or are involved in
joint mitochondrial pathways. However, we were not able
to detect any significant interaction based on a SNP × SNP
epistasis test between any of our nine potential candidate
genes.
Most of the SNPs we analysed are located in intronic or
intergenic regions, but may be in LD with functional cod-
ing or regulatory sequence variants. Considering our
recruitment policy, we expect a highly homogeneous
cohort as we applied strict diagnostic criteria. In addition,
the ethnicity of all of our patients was traced back to the
third generation. Therefore, we expect only small popula-
tion admixture when comparing our cohort with such
comprising a more genetically heterogeneous background
(like for example the Unites States). As the homogeneity
of a population corresponds with the persistence of LD
between a genetic marker and a disease gene, the power to
detect an association is higher in homogeneous popula-
tions. The homogeneity of our samples therefore may
compensate in part for the small number of individuals.
However, we are aware of the fact that our study is not
well-powered for statistical testing. A retrospective power
calculation based upon an OR of 1.558 (for SNP
rs765884 which showed the strongest association) indi-
cated that this study was sufficiently powered (91,8%; α =
0.05) to detect an effect of this magnitude or greater
before correction for multiple comparisons. After Bonfer-
roni correction, the power was considerably reduced
(24,3%; α = 0.05).
Conclusion
The objective of this study was to investigate association
of several genes that have not been subject to an associa-
tion study with glaucoma cases so far but might be func-
tionally linked to glaucoma pathogenesis (RDX, SNX16,
MFN1, MFN2, PARL, SOD2). In addition, we analysed
genes that have been previously identified as candidate
genes in glaucoma (OPTN, OPA1, CYP1B1). Whereas we
could not detect any association of NTG with RDX,
SNX16, OPA1, SOD2 and CYP1B1, our study revealed a
trend towards association of NTG with common sequence
variants of OPTN, MFN1, MFN2 and PARL, the latter three
ones being involved in mitochondrial function.
Although our sample sizes are among the largest investi-
gated in NTG so far, it is important to point out that the
power of our study is still relatively limited. As we cannot
fully exclude type one or type two errors, it is essential to
replicate our findings in independent cohorts.
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